
aluxum/E+ via Getty Images
Tandem Diabetes (NASDAQ:TNDM) was downgraded to Neutral from Overweight at Piper Sandler following the company’s updated guidance, reflecting increased uncertainty and a softer outlook in key areas.
While the company reported Q2 results above estimates, Piper Sandler analysts feel the domestic